Corporate Vision

We devote ourselves to research and development of various modalities (pharmaceuticals, medical devices, artificial intelligence (AI)) in the medical setting to solve the medical issues, and create new medical care to enable people to enjoy lifelong health, both physically and mentally.

Creating New Medical Value

As the super-aging of society progresses in developed countries, including Japan, the discrepancy of approximately 10 years between average life expectancy and healthy life expectancy (the period during which one can live independently in both physical and mental health, minus the period of nursing care required, such as being bedridden or suffering from dementia) has become a major issue. Treating various age-related diseases, such as cancer, cardiovascular disease, respiratory disease, and diabetes mellitus, can lead to an extension of healthy life expectancy. These four diseases account for approximately 80% of global deaths and are identified by the World Health Organization (WHO) as important diseases associated with aging and lifestyle-related conditions. We are working to solve important medical and social issues, including developing pharmaceuticals to extend healthy life expectancy, including treatments for these four diseases, as well as treatments for women’s and children’s diseases.

In addition to specific age-related diseases such as cancer, cardiovascular disease, respiratory disease, and diabetes, we are also focusing on research and business in the “longevity” field, which is expected to see international business growth. Until now, anti-aging and longevity treatments have mainly focused on dietary therapy, exercise therapy, supplements, and functional foods. Our company is challenging to create new medical value, such as a senolytic drug (an oral medication that remove senescent cells and suppress aging-related diseases without promoting cancer).